In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium

Clinical and Experimental Dermatology

Volumn 32, Issue 6, 2007, Pages 675-679

  Sarifakioglu, E ^a,b   Seckin D ^a   Demirbilek, M ^a   Can, F ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b FATIH UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; FLUCONAZOLE; ITRACONAZOLE; PYRROLE DERIVATIVE; TERBINAFINE;

ADULT; ARTICLE; BIOASSAY; CONTROLLED STUDY; DERMATOPHYTE; DRUG SENSITIVITY; FEMALE; GROWTH INHIBITION; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; ONYCHOMYCOSIS; PRIORITY JOURNAL; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM;

ADULT; ANTIFUNGAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION; DRUG RESISTANCE, FUNGAL; FEMALE; FLUCONAZOLE; HUMANS; ITRACONAZOLE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NAPHTHALENES; ONYCHOMYCOSIS; TRICHOPHYTON;

EID: 35348982858     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2007.02480.x     Document Type: Article

References (24)

1. Ghannoum MA, Hajjeh RA, Scher R et al. A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. J Am Acad Dermatol 2000 43 : 641 8.
2. Masia Canuto M, Gutierrez Rodero F. Antifungal drug resistance to azoles and polyenes. Lancet Infect Dis 2002 2 : 550 63.
3. Goy CL, Tay YK, Ali KB et al. In vitro evaluation of griseofulvin, ketoconazole, and itraconazole against various dermtophytes in Singapore. Int J Dermatol 1994 33 : 733 7.
4. Holmberg K. In vitro assessment of antifungal drug resistance. Acta Derm Venereol (Stockh) 1986 121 : 131 8.
5. Gupta AK, Kohli Y. Evaluation of in vitro resistance in patients with onychomycosis who fail antifungal therapy. Dermatology 2003 207 : 375 80.
6. Ghannoum MA, Chaturverdi V, Espinel-Ingroff A et al. Intra-and interlaboratory study of a method for testing the antifungal susceptibilities of dermatophytes. J Clin Microbiol 2004 42 : 2977 9.
7. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Susceptibility Testing of Yeast. Approved Standard M27-A. Villanova, Pa : National Committee for Clinical Laboratory Standards, 1997.
8. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Susceptibility Testing of Conidium-Forming Filamentous Fungi: Proposed Standard. M38-P. Wayne, Pa : National Committee for Clinical Laboratory Standards, 1998
9. Weitzman I, Summerbell RC. The dermatophytes. Clin Microbiol Rev 1995 8 : 240 59.
10. Fernández-Torres B, Carillo AJ, Martin E et al. In vitro activities of 10 antifungal drugs against 508 dermatophyte strains. Antimicrob Agents Chemother 2001 45 : 2524 8.
11. Perea S, Fothergill AW, Sutton DA, Rinaldi MG. Comparison of in vitro activities of voriconazole and five established antifungal agents against different species of dermtophytes using broth macrodilution method. J Clin Microbiol 2001 39 : 385 8.
12. Gupta AK, Kohli Y. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity. Br J Dermatol 2003 149 : 296 305.
13. Fernández-Torres B, Cabañes FJ, Carrillo-Muñoz AJ et al. Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes. J Clin Microbiol 2002 40 : 3999 4003.
14. Fernández-Torres B, Vázquez-Veiga HL, Iovo X et al. In vitro susceptibility to itraconazole, clotrimazole, ketoconazole and terbinafine of 100 isolates of T. rubrum. Chemotherapy 2000 46 : 390 4.
15. Santos DA, Hamdan JS. In vitro antifungal oral drug and drug-combination activity against onychomycosis causative dermatophytes. Med Mycol 2006 44 : 357 62.
16. Hazen KC. Evaluation of in vitro susceptibility of dermatophytes to oral antifungal agents. J Am Acad Dermatol 2000 43 : S125 9.
17. Rex JH, Pfaller MA, Galgiani JN et al. Development of Interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Clin Infect Dis 1997 24 : 235 47.
18. Karaca N, Koc N. In vitro susceptibility testing of dermatophytes: comparison of disk diffusion and reference broth dilution methods. Diagn Microbial Infect Dis 2004 48 : 259 64.
19. Jessup CJ, Warner J, Isham N et al. Antifungal susceptibility testing of dermatophytes: establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates. J Clin Microbiol 2000 38 : 341 4.
20. Pfaller MA, Yu WL. Antifungal susceptibility testing: new technology and clinical applications. Infect Dis Clin North Am 2001 15 : 227 61.
21. Hoffman HL, Phaller MA. In vitro antifungal susceptibility testing. Pharmacotherapy 2001 21 : 111 23.
22. Norris HA, Elewski BE, Ghannoum MA. Optimal growth conditions for the determination of the antifungal susceptibility of three species of dermatophytes with the use of a microdilution method. J Am Acad Dermatol 1999 40 : 9 13.
23. Guarro J, Llop C, Aguilar C, Pujol I. Comparison of in vitro antifungal susceptibilities of conidia and hyphae of filamentous fungi. Antimicrob Agents Chemother 1997 41 : 2760 2.
24. Arikan S, Rex JH. New agents for the treatment of systemic fungal infections-current status. Expert Opin Emerg Drugs 2002 7 : 3 32.